Results 121 to 130 of about 24,588 (279)

Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies

Case Reports in Medicine, 2015
Chronic spontaneous urticaria is an itching skin disease characterised by wheals, angioedema, or both present for more than six weeks. Omalizumab is a humanized anti-IgE monoclonal antibody recently approved for treatment of chronic urticaria.
Misbah Nasheela Ghazanfar, Simon Francis Thomsen   +1 more
doaj   +1 more source

Exploring the Disease Duration of Urticaria and Associated Determinants in Primary Care

Clinical &Experimental Allergy, EarlyView.
R. Soegiharto, B. J. Hengevelt, N. Boekema‐Bakker, I. A. M. Groenewegen, A. C. Knulst, J. M. P. A. Van den Reek, H. Röckmann   +6 more
wiley   +1 more source

Therapeutic advances in pruritus as a model of personalized medicine

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Recent advances in itch biology reveal that chronic pruritus arises from distinct neuroimmune pathways driven by cytokines, JAK, BTK and GPCRs. Targeted biologics and small molecule inhibitors such as dupilumab, nemolizumab, remibrutinib and JAK inhibitors precisely modulate these pathways, leading to a new era of personalized therapeutics in pruritus.
Kelsey Auyeung, Ramsey Kubofcik, Brian S. Kim   +2 more
wiley   +1 more source

Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy

, 2020
Sayantani Sindher, Andrew Long, Natasha Purington, Divya Kumar, Stacey Skura, Margaret Woch, Tiffany Tan, Andres Alvarez, R. Sharon Chinthrajah, Maria Garcia-Lloret, Kari C. Nadeau   +10 more
openalex   +1 more source

Isolated Mast Cell–Mediated Angioedema: Clinically Different but Endotypically Similar to Chronic Spontaneous Urticaria

Clinical &Experimental Allergy, EarlyView.
Thomas Buttgereit, Claudia Hayford, Carolina Vera Ayala, Sherezade Moñino‐Romero, Yi‐Kui Xiang, Pavel Kolkhir, Carolin Steinert, Denise Freier, Markus Magerl, Jörg Scheffel, Karsten Weller   +10 more
wiley   +1 more source

Family quality‐of‐life burden in chronic spontaneous urticaria: A multicentre study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Poor control of chronic spontaneous urticaria (CSU) significantly worsens family members' quality of life, especially in emotional, physical, and social domains. Higher disease severity was linked to increased caregiving burden and household expenditures, highlighting the need for family‐centred CSU care and support across diverse global populations ...
Beatrice Martinez Zugaib Abdalla, Roberta Fachini Jardim Criado, Kanokvalai Kulthanan, Emek Kocatürk, Ivan Cherrez‐Ojeda, Ana Maria Giménez‐Arnau, Marcus Maurer, Luis Felipe Ensina, Jonathan A. Bernstein, Michihiro Hide, Sergio Duarte Dortas Junior, Solange Oliveira Rodrigues Valle, Gabriela Dias, Paraskevi Xepapadak, Priyanshi Dangi, Indrashis Podder, Vesna Trajkova, Natasa Teovska Mitrevska, Iman Hamed Nasr, Bushra Al Hinai, Joanna Bartosińska, Dorota Krasowska, Paulina Szczepanik‐Kułak, Hilal Gungor, Deniz Ozceker, Kübra Çiçek, Esen Özkaya, Yasemin Erdem, Mücahit Ergün, Mustafa Tosun, Rabia Oztas Kara, Jie Li, Anastasia Allenova, Paulo Ricardo Criado   +33 more
wiley   +1 more source

Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature [PDF]

, 2015
Misbah Nasheela Ghazanfar, Simon Francis Thomsen   +1 more
openalex   +1 more source

Omalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review

Pediatric Dermatology, EarlyView.
ABSTRACT We report an 11‐month‐old boy with diffuse cutaneous mastocytosis whose severe pruritus and steroid dependence resolved following off‐label treatment with omalizumab. A literature review identified five additional pediatric cases in which omalizumab led to complete symptom resolution in an average of 2 months and permitted discontinuation of ...
Janis Chang, Aliyah King, Adam Byrne, Carmen Liy‐Wong   +3 more
wiley   +1 more source

The many abilities of omalizumab and the unbeaten path [PDF]

, 2019
Cristoforo Incorvaia, G Riario-Sforza, Erminia Ridolo   +2 more
openalex   +1 more source

Peripheral Blood Skin‐Homing T Cells Define Immunological Endotypes in Atopic Dermatitis: A Case–Control Study in a Mexican Population

Health Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims Atopic dermatitis (AD) is a chronic inflammatory skin disease with marked immunological heterogeneity. T‐cell subsets expressing CLA, CCR4, and CCR10 are involved in skin inflammation, but their frequency and expression patterns in AD remain poorly characterized.
Zumaya‐Pérez Luis Carlos, Velázquez‐Sámano Guillermo, Velasco‐Medina Andrea Aida, Garza‐Velasco Raúl, Rangel‐Castañeda Itzia Azucena, Moreno‐Eutimio Mario Adán, Pastelin‐Palacios Rodolfo   +6 more
wiley   +1 more source